전주홍 교수
Joo-Hong Jeon
서울대학교 생리학과 · 의학
연구실 소개
전주홍 교수의 연구실은 암 생물학과 대사질환의 분자 기전을 중심으로, 자연계에서 유래한 미세분자(예: 테르펜)의 항암 및 세포 보호 작용을 기반으로 한 신약 탐색을 주요 연구 방향으로 삼고 있습니다. 특히 프로스타테이트 세포에서의 세포 사멸 유도 메커니즘과 transglutaminase 효소의 구조 기반 기능 조절을 통해 암 및 신경퇴행성 질환의 치료 전략을 모색하고 있습니다. 최근에는 유전자 발현 전역 분석과 전사 인자 네트워크 분석을 통해 약물의 표적 기전을 규명하는 정밀의학 기반 연구도 진행 중입니다.
연구 현황
연구 성과 추이
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
주요 논문
15Geraniol, an acyclic dietary monoterpene, suppresses prostate cancer growth and enhances docetaxel chemosensitivity in cultured cell or xenograft tumor models. However, the mechanisms of the geraniol action against prostate cancer are largely unknown. In this study, we investigated the cellular and molecular mechanisms of geraniol-induced cell death in PC-3 prostate cancer cells. Among the examined structurally and functionally similar monoterpenes, geraniol potently induced apoptosis and autoph
Transglutaminase2 (TG2) is a multi-functional protein involved in various cellular processes, including apoptosis, differentiation, wound healing, and angiogenesis. The malfunction of TG2 causes many human disease including inflammatory disease, celiac disease, neurodegenerative diseases, tissue fibrosis, and cancers. Protein cross-linking activity, which is representative of TG2, is activated by calcium ions and suppressed by GTP. Here, we elucidated the structure of TG2 in complex with its end
Abstract Geraniol, an acyclic dietary monoterpene, has been found to suppress cancer survival and growth. However, the molecular mechanism underlying the antitumor action of geraniol has not been investigated at the genome‐wide level. In this study, we analyzed the microarray data obtained from geraniol‐treated prostate cancer cells. Geraniol potently altered a gene expression profile and primarily down‐regulated cell cycle‐related gene signatures, compared to linalool, another structurally simi
The treatment of cystamine, a transglutaminase(TGase) inhibitor, has beneficial effects in several diseases including CAG-expansion disorders and cataract. We compared the inhibition characteristics of cystamine with those of cysteamine, a reduced form of cystamine expect-ed to be present inside cells. Cystamine is a more potent inhibitor for TGase than cysteamine with different kinetics pattern in a non-reducing condition. By contrast, under reducing conditions, the inhibitory effect of cystami
The treatment of cystamine, a transglutaminase (TGase) inhibitor, has beneficial effects in several diseases including CAG-expansion disorders and cataract. We compared the inhibition characteristics of cystamine with those of cysteam ine, a reduced form of cystamine expected to be present inside cells. Cystamine is a more potent inhibitor for TGase than cysteamine with different kinetics pattern in a nonreducing condition. By contrast, under reducing conditions, the inhibitory effect of cystami
BACKGROUND: Diabetic individuals have increased circulating inflammatory mediators which are implicated as underlying causes of neuroinflammation and memory deficits. Tonicity-responsive enhancer-binding protein (TonEBP) promotes diabetic neuroinflammation. However, the precise role of TonEBP in the diabetic brain is not fully understood. METHODS: We employed a high-fat diet (HFD)-only fed mice or HFD/streptozotocin (STZ)-treated mice in our diabetic mouse models. Circulating TonEBP and lipocali
대표 연구 분야
전주홍 교수의 연구를 Nubint에서 더 깊이 살펴보세요
이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.